Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryosurgery and Multiplex Immunochemotherapy in Metastatic Solid Cancer
NCT04713371Phase 2Active, not recruiting
- Sponsor
- Rampart Health
- Start
- May 2021
- Primary completion
- Dec 2024
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab, ipilimumab, cyclophosphamide, sargramostim in solid tumor, sponsored by Rampart Health. Started May 2021; status: active, not recruiting.
02
Drugs
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04713371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04713371.